- ICH GCP
- USA klinikai vizsgálatok nyilvántartása
- Klinikai vizsgálat NCT05106933
The Effect of Carbohydrate Loading 2 Hours Before Gastroscopy on Gastric Residual Volume and Patient's Well-being Score (Carborie)
The Effect of Carbohydrate Loading 2 Hours Before Upper Endoscopy on Gastric Residual Volume and Patient's Well-being Score : A Single-Blind, Randomized Controlled Trial Study
A tanulmány áttekintése
Állapot
Körülmények
Beavatkozás / kezelés
Részletes leírás
Patient planned for OGDS in HUSM will be randomized into 2 groups. Plain water is given to group A of subject and carbohydrate loading is given to group B subject 2 hours before OGDS. Gastric residual volume is visualized directly and measured through aspiration via OGDS and subject's well-being is assessed for both group of the subject prior and after clear fluid have been given.
Methodology :
Research design :- This is a single-blind randomized controlled trial. This is a stratified (diabetes mellitus, non-diabetes mellitus) with balanced randomization (1:1), placebo-controlled study Study area :- This study will be conducted in the endoscopy room, Hospital Universiti Sains Malaysia (HUSM) in Kubang Kerian, Kelantan, Malaysia
All subjected planned for OGDS with the complaint of one or more of the following symptoms : Bothersome postprandial fullness, early satiety, epigastric pain or epigastric burning and fulfill the inclusion criteria are selected. Patients will be approached and be explained regarding the study in surgical outpatient clinic before OGDS. The patient will be approached again on the day of OGDS, if agree to participate, informed consent will be obtained. Informed consent will be obtained after explanation regarding the study and procedure again by researcher nurse.
The allocation sequence is according to computer-generated random number list, it was prepared by an investigator with no clinical involvement in the trial. The allocation sequence was concealed from researcher enrolling and assessing participants. The allocation sequence will be sealed in sequentially numbered and opaque envelopes. A manila card will be placed inside envelop to render it impermeable to intense light. To prevent subversion of the allocation sequence, the name and identification number of the participants will be written on a book together with the series number on the envelope. The details in the book will be kept confidentially.
After enrolled subject complete all the baseline assessment, the corresponding envelope will be enclosed by the trained staff (who not involved in the study) who prepare the drink. The staff need to ensure that the envelop is still sealed when receiving it. The staff will prepare the drink into an identical container according to the assignment.
The subjects are randomized into 2 groups: 1 group with 400mL plain water and another group given 1 packet carborie (400mL). Subjects need to finish the drink over 10 minutes. After that, subjects are not allowed to leave endoscope room until finish OGDS to prevent consumption of other drink or food.
2 hours after that, the subject undergoes OGDS. OGDS is performed following the standard protocol.
- The patient lies in the left lateral position
- Medication/lignocaine spray to numb the back of throats (spray) will be given to prevent gagging during the passage of the instrument
- A plastic mouth guard (mouthpiece) is placed between the teeth to prevent damage to the teeth and endoscope
- The endoscope (also called a gastroscope) will be inserted through the mouthpiece
- A small container or yankauer suction is placed close to the mouth of a patient to collect saliva during and after the oesophagogastroduodenoscopy (OGDS)
- The endoscope will be inserted along the middle line of the soft palate
- Once endoscope advanced, the patient may be asked to swallow to facilitate advancement of scope
- Throughout the procedure, no water flushing is allowed, only air inflation is allowed.
Visualized pooling of fluid in the stomach is aspirated until dry via direct visualization with the endoscope. The aspirated fluid will be collected in the suction reservoir and the fluid will be measured
Subject's well-being score is assessed via visual analogue scale (VAS) which consist of 5 parameters: hunger, thirst, anxiety, tiredness and general discomfort. This scale will be used repeatedly during this study to assess the patient's well-being. The trained staff nurse will ask the patient regarding the level of 5 parameters and subject need to mark [X] somewhere along the horizontal line given before drink and before OGDS procedure.
All subjects are advised to inform assessor if there is an adverse reaction. Medical personnel are available to manage any adverse events that might occur throughout the procedure.
The possible risk that may arise in the study includes injury to the gastrointestinal wall, aspiration and bleeding which is the similar risk for all patient undergoing for OGDS procedure. The small volume of the drink will not cause psychological distress to the subject, but its taste may not be palatable.
Tanulmány típusa
Beiratkozás (Tényleges)
Fázis
- Nem alkalmazható
Kapcsolatok és helyek
Tanulmányi helyek
-
-
Kelantan
-
Kota Bharu, Kelantan, Malaysia, 15200
- Department of General Surgery
-
-
Részvételi kritériumok
Jogosultsági kritériumok
Tanulmányozható életkorok
Egészséges önkénteseket fogad
Tanulmányozható nemek
Leírás
Inclusion Criteria:
- Patient 18 years old and above
- Agree to participate
Exclusion Criteria:
- History of upper gastrointestinal surgery
- Patient with active gastrointestinal bleeding
- Unstable clinical condition
- Mentally disable or who cannot give an informed consent
- Patient on the nasogastric feeding tube
- Pregnant patient
- American Society of Anesthesiologists classification of physical status grade 3 or above
- Insulin dependent Diabetes Mellitus more than 10 years
- Patient who is carbohydrate intolerance
Tanulási terv
Hogyan készül a tanulmány?
Tervezési részletek
- Elsődleges cél: Kezelés
- Kiosztás: Véletlenszerűsített
- Beavatkozó modell: Párhuzamos hozzárendelés
- Maszkolás: Négyszeres
Fegyverek és beavatkozások
Résztvevő csoport / kar |
Beavatkozás / kezelés |
|---|---|
|
Placebo Comparator: Plain water
Group A patient will be given 400cc of plain water, 2 hours prior to gastroscopy
|
Measure gastric residual volume during upper endoscopic, after given plain water and carborie 2 hours prior upper endoscopy
|
|
Kísérleti: Carborie
Group B patient will be given 400cc of carborie (carbohydrate drink), 2 hours prior to gastroscopy
|
carbohydrate drink
|
Mit mér a tanulmány?
Elsődleges eredményintézkedések
Eredménymérő |
Intézkedés leírása |
Időkeret |
|---|---|---|
|
To compare the gastric residual volume 2 hours after carbohydrate loading (intervention group) and plain water group (control group)
Időkeret: 2 hour before OGDS
|
Patients will be randomised into control group and intervention group.
Those in intervention group will have to drink clear water containing carbohydrate (carborie) 2 hours prior to gastroscopy.
Endoscopist will measure patient's gastric residual volume.
Residual gastric fluid will be aspirated into the container, final volume will be measured.
|
2 hour before OGDS
|
Másodlagos eredményintézkedések
Eredménymérő |
Intézkedés leírása |
Időkeret |
|---|---|---|
|
To compare the patient's well-being after ingestion of carbohydrate loading (intervention group) and plain water (control group)
Időkeret: 2 hours
|
To assess patient well-being score before and after giving carborie load.
Visual analogue scale (VAS) used for assessment of patient well-being.
Just before and after the ingestion of the clear fluid patients are told to indicate the level of discomfort on a visual analogue scale which ranged from 0mm to 100mm.
Zero signifying not at all while 100 signify the most imaginable/maximum discomfort.
|
2 hours
|
Egyéb eredményintézkedések
Eredménymérő |
Intézkedés leírása |
Időkeret |
|---|---|---|
|
To assess the effect of carbohydrate loading in patient planned for OGDS in HUSM
Időkeret: 2 hours prior OGDS
|
To assess gastric residual volume 2 hour prior OGDS
|
2 hours prior OGDS
|
Együttműködők és nyomozók
Szponzor
Nyomozók
- Tanulmányi igazgató: Nizam Hashim, Master, HUSM, Kubang Kerian, Malaysia
Publikációk és hasznos linkek
Általános kiadványok
- American Society of Anesthesiologists Committee. Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration: application to healthy patients undergoing elective procedures: an updated report by the American Society of Anesthesiologists Committee on Standards and Practice Parameters. Anesthesiology. 2011 Mar;114(3):495-511. doi: 10.1097/ALN.0b013e3181fcbfd9. No abstract available.
- Qureshi WA, Zuckerman MJ, Adler DG, Davila RE, Egan JV, Gan SI, Lichtenstein DR, Rajan E, Shen B, Fanelli RD, Van Guilder T, Baron TH; Standards of Practice Committee, American Society for Gastrointestinal Endoscopy. ASGE guideline: modifications in endoscopic practice for the elderly. Gastrointest Endosc. 2006 Apr;63(4):566-9. doi: 10.1016/j.gie.2006.02.001. No abstract available.
- De Silva AP, Amarasiri L, Liyanage MN, Kottachchi D, Dassanayake AS, de Silva HJ. One-hour fast for water and six-hour fast for solids prior to endoscopy provides good endoscopic vision and results in minimum patient discomfort. J Gastroenterol Hepatol. 2009 Jun;24(6):1095-7. doi: 10.1111/j.1440-1746.2009.05782.x. Epub 2009 Feb 12.
- Sabry R, Hasanin A, Refaat S, Abdel Raouf S, Abdallah AS, Helmy N. Evaluation of gastric residual volume in fasting diabetic patients using gastric ultrasound. Acta Anaesthesiol Scand. 2019 May;63(5):615-619. doi: 10.1111/aas.13315. Epub 2019 Jan 4.
- Spada C, McNamara D, Despott EJ, Adler S, Cash BD, Fernandez-Urien I, Ivekovic H, Keuchel M, McAlindon M, Saurin JC, Panter S, Bellisario C, Minozzi S, Senore C, Bennett C, Bretthauer M, Dinis-Ribeiro M, Domagk D, Hassan C, Kaminski MF, Rees CJ, Valori R, Bisschops R, Rutter MD. Performance measures for small-bowel endoscopy: A European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. United European Gastroenterol J. 2019 Jun;7(5):614-641. doi: 10.1177/2050640619850365. Epub 2019 May 15.
Tanulmányi rekorddátumok
Tanulmány főbb dátumok
Tanulmány kezdete (Tényleges)
Elsődleges befejezés (Tényleges)
A tanulmány befejezése (Tényleges)
Tanulmányi regisztráció dátumai
Először benyújtva
Először nyújtották be, amely megfelel a minőségbiztosítási kritériumoknak
Első közzététel (Tényleges)
Tanulmányi rekordok frissítései
Utolsó frissítés közzétéve (Tényleges)
Az utolsó frissítés elküldve, amely megfelel a minőségbiztosítási kritériumoknak
Utolsó ellenőrzés
Több információ
A tanulmányhoz kapcsolódó kifejezések
Kulcsszavak
Egyéb vizsgálati azonosító számok
- HUSM Malaysia
Terv az egyéni résztvevői adatokhoz (IPD)
Tervezi megosztani az egyéni résztvevői adatokat (IPD)?
Gyógyszer- és eszközinformációk, tanulmányi dokumentumok
Egy amerikai FDA által szabályozott gyógyszerkészítményt tanulmányoz
Egy amerikai FDA által szabályozott eszközterméket tanulmányoz
Ezt az információt közvetlenül a clinicaltrials.gov webhelyről szereztük be, változtatás nélkül. Ha bármilyen kérése van vizsgálati adatainak módosítására, eltávolítására vagy frissítésére, kérjük, írjon a következő címre: register@clinicaltrials.gov. Amint a változás bevezetésre kerül a clinicaltrials.gov oldalon, ez a webhelyünkön is automatikusan frissül. .
Klinikai vizsgálatok a A gyomor maradék térfogata
-
Hospital Universitari Vall d'Hebron Research InstituteBefejezveLiposomált vas | Y-de-Roux Gastric By-Pass | Parenterális vasterápiaSpanyolország
-
University Hospital, CaenMég nincs toborzásCurarization, Postoperative ResidualFranciaország
-
Campus Bio-Medico UniversityIsmeretlenCurarization, Postoperative ResidualOlaszország
-
AkesoToborzásGastric and Gastroesophageal Junction (GEJ) adenocarcinomaKína
-
DuomedAktív, nem toborzóElhízottság | Gastrectomia | Roux-en-Y gyomor-bypass | Mini Gastric BypassBelgium
-
Mansoura UniversityIsmeretlenHelicobacter pylori | Gastric Antrum | KORPUSZBIOPSIÁKEgyiptom
-
Xianmin Song, MDToborzás
-
Ruijin HospitalToborzásGastric and Gastroesophageal Junction (GEJ) adenocarcinomaKína
-
Ruijin HospitalAktív, nem toborzóGastric and Gastroesophageal Junction (GEJ) adenocarcinomaKína
-
Hospital do Divino Espírito Santo de Ponta DelgadaBefejezveÉrzéstelenítés | Neuromuszkuláris blokád | TOF | Curarization, Postoperative ResidualPortugália
Klinikai vizsgálatok a Plain water
-
Water Pik, Inc.Befejezve
-
George Washington UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)BefejezveCukorbetegség, 2-es típusúEgyesült Államok
-
Procter and GambleBefejezve
-
Instituto de Cardiologia do Rio Grande do SulBefejezve
-
Water Pik, Inc.MegszűntImplantátum körüli nyálkahártyagyulladásEgyesült Államok
-
University of NebraskaVisszavontHasmenéses epizódokIndia
-
University of Novi Sad, Faculty of Sport and Physical...Befejezve
-
All Sum Research Center Ltd.Water Pik, Inc.BefejezveLágyszöveti sérülések
-
University Hospital, AntwerpIsmeretlen
-
Johnson & Johnson Pte LtdShanghai China-Norm Management Consulting co.,LTD; Shanghai Skin Disease HospitalBefejezveA felnőtt bőr egészségének jeleiKína